CRP and COVID-19: Initially, several independent clinical studies observed elevated levels of D-dimer and CRP (independently as well as in combination with other biomarkers) in hospitalized and/or critically ill COVID-19 patients linked with hyperinflammation [40]; later found to be associated with increased hospitalization risk (linked to the severity of infection) and/or mortality risk in such patients.